2030 Biotech Ecosystems 
Frost & Sullivan
APRIL 14, 2025
By 2030, the sector is projected to generate an additional $3 billion in revenue. What was once a reactive ingredient category has now become a strategic growth lever powering immunity, metabolic health, womens wellness, beauty-from-within, and sports performance unified by data-rich ecosystems and next-gen traceability.
Frost & Sullivan
MAY 9, 2025
billion by 2030. This article explores the key trends, market drivers, and emerging opportunities in the pharmaceutical clinical contract peripheral services market from 2024 to 2030. The global CRO industry, valued at $66.39 billion in 2024, is projected to grow at a CAGR of 10.7%, reaching $122.13
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frost & Sullivan
MARCH 5, 2025
Middle East: Governments are building closed-loop battery recycling ecosystems , attracting global recyclers like Li-Cycle and Umicore. Middle East: Vision 2030 is driving generative design adoption in real estate and infrastructure. Regional Insights: India: 15% CAGR projected , led by Amara Raja, Exide, and Lohum Cleantech.
Frost & Sullivan
MARCH 13, 2025
This transformation is not only reshaping the operational landscape of surgical practices but also creating new opportunities for growth across various sectors within the healthcare ecosystem. Want deeper insights? Download our full Global Digital Surgery Analysis for key strategic imperatives and growth opportunities. Want deeper insights?
Frost & Sullivan
MARCH 28, 2025
million by 2030, emphasizing the need for early and accurate diagnostics. Competitive Landscape: Industry Players and Ecosystem The global cardiac biomarkers diagnostics market is moderately competitive, with major players driving innovation. Download our full analysis on Cardiac Biomarkers Diagnostics. Elabscience Biotechnology, Inc.,
Expert insights. Personalized for you.
52 
Let's personalize your content